@davlei_healing's peptide therapy claims, fact-checked

What does this Instagram post actually claim?

@davlei_healing promotes four peptides as therapeutic solutions for women going through perimenopause and menopause. The med spa promises BPC-157 heals guts and tames inflammation, NAD+ boosts energy and repairs cells, Tesamorelin reduces belly fat while preserving muscle, and GHK-Cu works "skin, hair, and collagen magic."

The post positions these peptides as alternatives to well-known options like Ozempic, suggesting they can help women "heal, repair, and actually thrive" during hormonal transitions. It's classic wellness marketing that takes legitimate research and stretches it into broad health promises.

Does the science actually support these claims?

The evidence is surprisingly thin for most of these promises. BPC-157 studies exist only in rats and test tubes, not humans. A 2020 review by Chang et al. in Biomedicines found promising wound healing in rodents, but zero clinical trials in people.

Tesamorelin has the strongest evidence. The TES-1 trial (Stanley et al., AIDS, 2010) showed 15.2% reduction in visceral fat in HIV patients after 26 weeks. But that's HIV lipodystrophy, not menopause-related weight gain.

NAD+ and GHK-Cu research is mostly preliminary. Small pilot studies suggest potential benefits, but calling NAD+ a proven energy booster oversells what we actually know from rigorous trials.

What did they get wrong about peptide regulation?

Here's the bigger issue: most of these peptides aren't FDA-approved for the conditions this post targets. BPC-157 isn't approved for anything in humans. The FDA has actually sent warning letters to companies selling it as a supplement.

Tesamorelin is FDA-approved, but only for HIV-associated lipodystrophy. Using it for general "belly fat reduction" in menopausal women is off-label prescribing that lacks supporting data.

The post makes these sound like established therapies when they're really experimental treatments with limited human evidence. That's misleading for people seeking legitimate menopause care.

What should you actually know about peptide therapy?

Peptides aren't automatically safer just because they're "natural." They're still bioactive compounds that can cause side effects. Tesamorelin can cause joint pain and fluid retention. NAD+ infusions have caused nausea and fatigue in some patients.

The peptide therapy field is largely unregulated. Many peptides sold by compounding pharmacies or wellness clinics haven't undergone proper safety testing in humans.

If you're dealing with perimenopause or menopause symptoms, proven treatments exist. Hormone replacement therapy has decades of research. The Women's Health Initiative and subsequent studies provide clear data on benefits and risks that you won't find with experimental peptides.